MUC1-Activated T Cells for the Treatment of Relapsed and Resistant Ovarian Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Bendamustine
Related studies linked through entity extraction aliases.
A Study of IMM01 Plus Tiselizumab Versus Physician's Choice Chemotherapy in PD(L)1-refractory Classical Hodgkin Lymphoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
A Study to Evaluate the Efficacy and Safety of Golcadomide in Combination With Rituximab in Participants With Newly Diagnosed Advanced Stage Follicular Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study to Evaluate the Efficacy and Safety of Liso-cel Compared to Standard of Care in Adults With Relapsed or Refractory Follicular Lymphoma
- Status
- WITHDRAWN
- Phase
- PHASE3
A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
- Status
- RECRUITING
- Phase
- PHASE1
FT825/ONO-8250, an Off-the-Shelf, HER2 CAR-T, With or Without Monoclonal Antibodies in Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
A Study to Compare the Efficacy and Safety of Lisocabtagene Maraleucel vs Investigator's Choice Options in Adult Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma, Whose Disease Has Failed Treatment With Both BTKi and BCL2i Therapies
- Status
- WITHDRAWN
- Phase
- PHASE3
B-Cell Activating Factor Receptor (BAFFR)-Based Chimeric Antigen Receptor T-Cells With Fludarabine and Cyclophosphamide Lymphodepletion for the Treatment of Relapsed or Refractory B-cell Hematologic Malignancies
- Status
- RECRUITING
- Phase
- PHASE1
Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Previously Untreated Follicular Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Autologous T Cells Lentivirally Transduced to Express L1CAM-Specific Chimeric Antigen Receptors in Treating Patients With Locally Advanced and Unresectable or Metastatic Small Cell Neuroendocrine Prostate Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1
A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular Lymphoma
- Status
- RECRUITING
- Phase
- PHASE3
A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell Lymphoma
- Status
- RECRUITING
- Phase
- PHASE3
Autologous CD8+ and CD4+ Transgenic T Cells Expressing High Affinity KRASG12V Mutation-Specific T Cell Receptors (FH-A11KRASG12V-TCR) in Treating Patients With Metastatic Solid Tumor Cancers With KRAS G12V Mutations
- Status
- RECRUITING
- Phase
- PHASE1
Mosunetuzumab-Lenalidomide Versus Investigator Choices in Patients With Relapsed or Refractory Marginal Zone Lymphoma
- Status
- RECRUITING
- Phase
- PHASE3
A Phase 2 Clinical Trial to Evaluate Zanubrutinib Combined With BR (Bendamustine/Rituximab) Regimen in Subjects With Newly-diagnosed Waldenström's Macroglobulinemia
- Status
- RECRUITING
- Phase
- PHASE2
FT522 With Rituximab in Relapsed/Refractory B-Cell Lymphoma (FT522-101)
- Status
- COMPLETED
- Phase
- PHASE1
FT596 in Combination With R-CHOP in Subjects With B-Cell Lymphoma
- Status
- WITHDRAWN
- Phase
- PHASE1
A Real-world Study of Obinutuzumab-based Therapy for Previously Untreated FL
- Status
- RECRUITING
- Phase
- N/A
Relapsed Follicular Lymphoma Randomised Trial Against Standard ChemoTherapy
- Status
- RECRUITING
- Phase
- PHASE2
A Trial Comparing Chemotherapy Versus Novel Immune Checkpoint Inhibitor (Pembrolizumab) Plus Chemotherapy in Treating Relapsed/Refractory Classical Hodgkin Lymphoma
- Status
- WITHDRAWN
- Phase
- PHASE3